Filing Details
- Accession Number:
- 0001127602-18-001398
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-01-08 17:07:54
- Reporting Period:
- 2018-01-05
- Accepted Time:
- 2018-01-08 17:07:54
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1613103 | Medtronic Plc | MDT | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1610035 | Hooman Hakami | 710 Medtronic Pkwy Ms Lc300 Minneapolis MN 55432 | Evp & Group President Diabetes | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Ordinary Shares | Acquisiton | 2018-01-05 | 26,158 | $62.76 | 91,986 | No | 4 | M | Direct | |
Ordinary Shares | Disposition | 2018-01-05 | 26,158 | $85.00 | 65,828 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Ordinary Shares | Stock Option (Right to Buy) | Disposition | 2018-01-05 | 26,158 | $0.00 | 26,158 | $62.76 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
26,159 | 2024-07-28 | No | 4 | M | Direct |
Footnotes
- This balance increased by 356 shares due to exempt transactions such as dividend reinvestment.
- The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- This option to purchase 1,594 ordinary shares of New Medtronic for $62.76 per share, which was unvested at the effective time of the Merger, was received in the Merger and represents the conversion of 1,594 Medtronic common stock shares for $62.76 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.
- This option to purchase 29,743 New Medtronic ordinary shares for $62.76 per share, which was unvested at the effective time of the Merger, was received in the Merger and represents the conversion of 29,743 Medtronic common stock shares for $62.76 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.
- This option to purchase 73,296 New Medtronic ordinary shares for $62.76 per share, which was unvested at the effective time of the Merger, was received in the Merger and represents the conversion of 73,296 Medtronic common stock shares for $62.76 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.